Journal of Cardiac Failure
Volume 16, Issue 2 , Pages 150-156 , February 2010

Patients' Self-Assessed Functional Status in Heart Failure by New York Heart Association Class: A Prognostic Predictor of Hospitalizations, Quality of Life and Death

  • Richard Holland, BA, BM, BCh, DPH, PhD, FFPH

      Affiliations

    • School of Medicine, Health Policy and Practice, University of East Anglia, Norwich, UK
    • Corresponding Author InformationReprint requests: Dr Richard Holland, School of Medicine, Health Policy and Practice, University of East Anglia, Norwich, UK. Tel.: +44(0)1603 593574; Fax: 44(0)1603 593752.
    • ,
  • Boika Rechel, MD, MSc, MPH, PhD

      Affiliations

    • School of Medicine, Health Policy and Practice, University of East Anglia, Norwich, UK
    • ,
  • Karolina Stepien, MD, PhD, MSc

      Affiliations

    • Queen's Medical Centre, Nottingham, UK
    • ,
  • Ian Harvey, BA, MB, BCh, PhD, FFPH

      Affiliations

    • School of Medicine, Health Policy and Practice, University of East Anglia, Norwich, UK
    • ,
  • Iain Brooksby, FRCP

      Affiliations

    • Norfolk & Norwich University Hospital NHS Trust, UK

Received 23 April 2009 ,Revised 21 August 2009 ,Accepted 31 August 2009.

References 

  1. Bennett JA, Riegel B, Bittner V, Nichols J. Validity and reliability of the NYHA classes for measuring research outcomes in patients with cardiac disease. Heart Lung. 2002;31:262–270
  2. The Criteria Committee of the New York Heart Association. Functional capacity and objective assessment. In:  Dolgin M editors. Nomenclature and criteria for diagnosis of diseases of the heart and great vessels. 9th ed. Boston, MA: Little, Brown and Company; 1994;p. 253–255
  3. Ekman I, Cleland JG, Andersson B, Swedberg K. Exploring symptoms in chronic heart failure. Eur J Heart Fail. 2005;7:699–703
  4. Madsen BK, Hansen JF, Stokholm KH, Brons J, Husum D, Mortensen LS. Chronic congestive heart failure. Description and survival of 190 consecutive patients with a diagnosis of chronic congestive heart failure based on clinical signs and symptoms. Eur Heart J. 1994;15:303–310
  5. Ahmed A, Aronow WS, Fleg JL. Higher New York Heart Association classes and increased mortality and hospitalization in patients with heart failure and preserved left ventricular function. Am Heart J. 2006;151:444–450
  6. Goldman L, Hashimoto B, Cook EF, Loscalzo A. Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale. Circulation. 1981;64:1227–1234
  7. Ekman I, Cleland JG, Swedberg K, Charlesworth A, Metra M, Poole-Wilson PA. Symptoms in patients with heart failure are prognostic predictors: insights from COMET. J Card Fail. 2005;11:288–292
  8. Ekman I, Kjork E, Andersson B. Self-assessed symptoms in chronic heart failure—important information for clinical management. Eur J Heart Fail. 2007;9:424–428
  9. Green CP, Porter CB, Bresnahan DR, Spertus JA. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J Am Coll Cardiol. 2000;35:1245–1255
  10. Subramanian U, Weiner M, Gradus-Pizlo I, Wu J, Tu W, Murray MD. Patient perception and provider assessment of severity of heart failure as predictors of hospitalization. Heart Lung. 2005;34:89–98
  11. Holland R, Brooksby I, Lenaghan E, Ashton K, Hay L, Smith R, et al. Effectiveness of visits from community pharmacists for patients with heart failure: HeartMed randomized controlled trial. BMJ. 2007;334:1098–1101
  12. Jitapunkul S, Pillay I, Ebrahim S. The abbreviated mental test: its use and validity. Age Ageing. 1991;20:332–336
  13. Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001;33:337–343
  14. Rector TS, Cohn JN. Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group. Am Heart J. 1992;124:1017–1025
  15. Watson R, Gibbs C, Lip G. ABC of heart failure: clinical features and complications. BMJ. 2000;320:236–239
  16. Rector TS, Tschumperlin LK, Kubo SH, Bank AJ, Francis GS, McDonald KM, et al. Use of the Living With Heart Failure questionnaire to ascertain patients' perspectives on improvement in quality of life versus risk of drug-induced death. J Card Fail. 1995;1:201–206
  17. van den Broek SA, van Veldhuisen DJ, de Graeff PA, Landsman ML, Hillege H, Lie KI. Comparison between New York Heart Association classification and peak oxygen consumption in the assessment of functional status and prognosis in patients with mild to moderate chronic congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1992;70:359–363
  18. Muntwyler J, Abetel G, Gruner C, Follath F. One-year mortality among unselected outpatients with heart failure. Eur Heart J. 2002;23:1861–1866
  19. Raphael C, Briscoe C, Davies J, Ian Whinnett Z, Manisty C, Sutton R, et al. Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure. Heart. 2007;93:476–482
  20. Bettencourt P, Ferreira A, Dias P, Pimenta J, Frioes F, Martins L, et al. Predictors of prognosis in patients with stable mild to moderate heart failure. J Card Fail. 2000;6:306–313

 Research costs were funded by a project grant from the British Heart Foundation (Grant number: PG/02/171). Excess treatment costs were funded by Great Yarmouth and Southern Norfolk Primary Care Trusts. The HeartMed trial received support for the educational training events from Pfizer UK. All researchers are independent from the British Heart Foundation who funded this study and from Pfizer UK who funded the educational events for the trial intervention.

 R.H. and B.R. designed this secondary analysis of the HeartMed trial data, K.S. wrote the first draft of the introduction for this paper, B.R. used that and produced the first full draft of the paper which was modified by R.H. I.B. and I.H. contributed to design and delivery of the original trial on which this subsequent analysis was based and all authors contributed to the final draft of this paper. R.H. is the guarantor for the data and this article.

 Ethical approval: Norwich District, King's Lynn, and Great Yarmouth and Waveney local research ethics committees.

 Conflict of interests: None.

PII: S1071-9164(09)01045-8

doi: 10.1016/j.cardfail.2009.08.010

Journal of Cardiac Failure
Volume 16, Issue 2 , Pages 150-156 , February 2010

Article Tools

* Image Usage & Resolution